University of Toronto

University / College


Location: Toronto, Canada (CA) CA

ISNI: 0000000121572938

ROR: https://ror.org/03dbr7087

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL (2022) Cobo MFL, Ritter J, Gary R, Seitz V, Mautner J, Aigner M, Völkl S, et al. Journal article The value of perioperative biomarker release for the assessment of myocardial injury or infarction in cardiac surgery (2022) Schneider U, Mukharyamov M, Beyersdorf F, Dewald O, Liebold A, Gaudino M, Fremes S, Doenst T Journal article, Review article Spatial Variations in Magmatic Volatile Influx and Fluid Boiling in the Submarine Hydrothermal Systems of Niuatahi Caldera, Tonga Rear-Arc (2022) Falkenberg J, Keith M, Haase K, Sporer C, Bach W, Klemd R, Strauss H, et al. Journal article, Original article Mysterious odd radio circle near the large magellanic cloud - an intergalactic supernova remnant? (2022) Filipovic MD, Payne JL, Alsaberi RZE, Norris RP, Macgregor PJ, Rudnick L, Koribalski BS, et al. Journal article Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium (2022) Kandzari DE, Mahfoud F, Weber MA, Townsend R, Parati G, Fisher NDL, Lobo MD, et al. Journal article Neuroendocrine Tumor Treatments and Follow-up Disease Management: Comparative Perspective (US and Canada vs Global) (2022) Kolarova T, Hollander R, Mcdonnell M, Bouvier C, Pavel ME, Singh H, Howe J, et al. Conference contribution [Lu-177]Lu-DOTA-TATE as First-line Therapy for Patients With Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): The NETTER-2 Study (2022) Singh S, Pavel ME, Kunz PL, De Herder W, Herrmann K, D'Amelio AM, Santoro P, et al. Conference contribution Meta-GWAS Reveals Novel Genetic Variants Associated with Urinary Excretion of Uromodulin (2022) Joseph CB, Mariniello M, Yoshifuji A, Schiano G, Lake J, Marten J, Richmond A, et al. Journal article Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients (2022) Mertens LS, Claps F, Mayr R, Bostrom PJ, Shariat SF, Zwarthoff EC, Boormans JL, et al. Journal article Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial (2022) Matteson EL, Kelly C, Distler J, Hoffmann-Vold AM, Seibold JR, Mittoo S, Dellaripa PF, et al. Journal article